Factors associated with serum B-type natriuretic peptide in infants with single ventricles

Ryan J. Butts, Victor Zak, Daphne Hsu, James Cnota, Steven D. Colan, David Hehir, Paul Kantor, Jami C. Levine, Renee Margossian, Marc Richmond, Anita Szwast, Derek Williams, Richard Williams, Andrew M. Atz

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Data regarding the value of B-type natriuretic peptide (BNP) measurements in infants with a single-ventricle (SV) physiology are lacking. This analysis aimed to describe the BNP level changes in infants with an SV physiology before and after superior cavopulmonary connection (SCPC) surgery. Levels of BNP were measured by a core laboratory before SCPC (at 5.0 ± 1.6 months) and at the age of 14 months during a multicenter trial of angiotensin-converting enzyme inhibition therapy for infants with SV. Multivariable longitudinal analysis was used to model the associations between BNP levels and three sets of grouped variables (echocardiography, catheterization, growth). Multivariable analysis was performed to assess associations with patient characteristics at both visits. Associations between BNP levels and neurodevelopmental variables were investigated at the 14 month visit because neurodevelopmental assessment was performed only at this visit. The BNP level was significantly higher before SCPC (n = 173) than at the age of 14 months (n = 134). The respective median levels were 80.8 pg/ml (interquartile range [IQR], 35-187 pg/ml) and 34.5 pg/ml (IQR, 17-67 pg/ml) (p < 0.01). A BNP level higher than 100 pg/ml was present in 72 subjects (42 %) before SCPC and in 21 subjects (16 %) at the age of 14 months. In the 117 patients who had BNP measurements at both visits, the median BNP level decreased 32 pg/ml (IQR, 1-79 pg/ml) (p < 0.01). In the longitudinal multivariable analysis, higher BNP levels were associated with a higher end-systolic volume z-score (p = 0.01), a greater degree of atrioventricular (AV) valve regurgitation (p < 0.01), a lower weight z-score (p < 0.01), and a lower length z-score (p = 0.02). In multivariable analyses, a higher BNP level at the age of 14 months was associated with arrhythmia after SCPC surgery (p < 0.01), a prior Norwood procedure (p < 0.01), a longer hospital stay after SCPC surgery (p = 0.04), and a lower Bayley psychomotor developmental index (p = 0.02). The levels of BNP decreases in infants with SV from the pre-SCPC visit to the age of 14 months. A higher BNP level is associated with increased ventricular dilation in systole, increased AV valve regurgitation, impaired growth, and poorer neurodevelopmental outcomes. Therefore, BNP level may be a useful seromarker for identifying infants with SV at risk for worse outcomes.

Original languageEnglish (US)
Pages (from-to)879-887
Number of pages9
JournalPediatric Cardiology
Volume35
Issue number5
DOIs
StatePublished - Jun 2014
Externally publishedYes

Keywords

  • Angiotensin-converting enzyme inhibition therapy
  • B-type natriuretic peptide
  • BNP
  • SCPC
  • Single-ventricle physiology
  • Superior cavopulmonary connection surgery
  • Ventricular dilation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Factors associated with serum B-type natriuretic peptide in infants with single ventricles'. Together they form a unique fingerprint.

  • Cite this

    Butts, R. J., Zak, V., Hsu, D., Cnota, J., Colan, S. D., Hehir, D., Kantor, P., Levine, J. C., Margossian, R., Richmond, M., Szwast, A., Williams, D., Williams, R., & Atz, A. M. (2014). Factors associated with serum B-type natriuretic peptide in infants with single ventricles. Pediatric Cardiology, 35(5), 879-887. https://doi.org/10.1007/s00246-014-0872-z